XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Preferred Shares
Common Shares
Additional Paid-in Capital
Distributions In Excess Of Earnings
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Beginning balances, preferred stock (in shares) at Dec. 31, 2022   9,017,588          
Beginning balances at Dec. 31, 2022 $ 2,389,014 $ 225,439 $ 898 $ 1,777,984 $ (396,650) $ 40,530 $ 740,813
Beginning balances, common stock (in shares) at Dec. 31, 2022     89,842,145        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of preferred shares (in shares)   5,668,128          
Issuance of preferred shares 113,274 $ 115,212   (1,938)      
Acquisition of properties 37,257           37,257
Issuance of Series A-1 preferred units 750           750
Redemptions of OP Units (in shares)     67,431        
Redemptions of OP Units 0   $ 1 1,093   30 (1,124)
Repurchase of common shares (in shares)     (1,622,874)        
Repurchase of common shares (69,311)   $ (16) (69,295)      
Effect of changes in ownership for consolidated entities 0     (18,720)   (1,245) 19,965
Equity-based compensation expense 1,649     101     1,548
Issuance of restricted common shares (in shares)     12,417        
Vesting and forfeitures of restricted common shares, net (in shares)     (2,977)        
Vesting and forfeitures of restricted common shares, net (89)     (89)      
Preferred share dividends (3,962)       (3,962)    
Common share dividends (48,755)       (48,755)    
Distributions to noncontrolling interests (34,431)           (34,431)
Other comprehensive loss (20,714)         (14,162) (6,552)
Net income 40,392       28,959   11,433
Ending balances, preferred stock (in shares) at Mar. 31, 2023   14,685,716          
Ending balances at Mar. 31, 2023 2,405,074 $ 340,651 $ 883 1,689,136 (420,408) 25,153 769,659
Ending balances, common stock (in shares) at Mar. 31, 2023     88,296,142        
Beginning balances, preferred stock (in shares) at Dec. 31, 2023   14,685,716          
Beginning balances at Dec. 31, 2023 $ 2,125,841 $ 340,651 $ 823 1,509,563 (449,907) 21,058 703,653
Beginning balances, common stock (in shares) at Dec. 31, 2023 82,285,995   82,285,995        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Redemptions of OP Units (in shares)     72,802        
Redemptions of OP Units $ (381)   $ 1 1,025   19 (1,426)
Repurchase of common shares (in shares) (5,491,925,000)   (5,491,925)        
Repurchase of common shares $ (203,573)   $ (55) (203,518)      
Effect of changes in ownership for consolidated entities 0     40,676   (620) (40,056)
Equity-based compensation expense 1,855     109     1,746
Issuance of restricted common shares (in shares)     8,886        
Issuance of restricted common shares 0     0      
Vesting and forfeitures of restricted common shares, net (in shares)     (2,658)        
Vesting and forfeitures of restricted common shares, net (88)     (88)      
Equity offering costs (255)     (255)      
Preferred share dividends (5,110)       (5,110)    
Common share dividends (43,751)       (43,751)    
Distributions to noncontrolling interests (33,653)           (33,653)
Other comprehensive loss 11,099         7,379 3,720
Net income 95,088       59,027   36,061
Ending balances, preferred stock (in shares) at Mar. 31, 2024   14,685,716          
Ending balances at Mar. 31, 2024 $ 1,947,072 $ 340,651 $ 769 $ 1,347,512 $ (439,741) $ 27,836 $ 670,045
Ending balances, common stock (in shares) at Mar. 31, 2024 76,873,100   76,873,100